Skip to main content
Market intelligence
IMNMHealthcare

Immunome Inc insider activity

In the last 90 days, 1 corporate insider purchased $511,580 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$511,580
Corporate buyers
1
Latest transaction
Jun 15, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 15, 2026Max RosettChief Financial OfficerSale60,000$18.23$1,093,800
Jun 5, 2026Jean Jacques BienaimeDirectorOpen Market Purchase21,000$19.43$408,080
May 15, 2026Jean Jacques BienaimeDirectorOpen Market Purchase5,000$20.70$103,500